Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trialsEmma Guttman‐Yassky, Alan D. Irvine, Norito Katoh et al.|The Lancet|2021Cited by 538
Rhizoma Paridis saponins attenuate Gram‐negative bacteria‐induced inflammatory acne by binding to <scp>KEAP1</scp> and modulating Nrf2 and <scp>MAPK</scp> pathwaysYang Yang, Qianghua Quan|Journal of Cellular and Molecular Medicine|2024Cited by 8